CSIMarket
 


Cellectar Biosciences Inc   (CLRB)
Other Ticker:  
 

Cumulative Cellectar Biosciences Inc 's Quick Ratio for Trailing Twelve Months Period

CLRB's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CLRB Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 109.82 % 61.08 % -7.85 % 11.96 % -20.96 %
Y / Y Cash & cash equivalent Growth -55.92 % -46.97 % -42.88 % -37.54 % 114.12 %
Quick Ratio for Trailing Twelve Months Period 5.39 7.8 10.37 11.63 13.4
Total Ranking # 625 # 570 # 466 # 435 # 287
Seq. Current Liabilities Growth 16.56 % 21.07 % 17.04 % 27.04 % -10.51 %
Seq. Cash & cash equivalent Growth -28.3 % -19.03 % -14.2 % -11.5 % -13.75 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $6 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 5.39 below Cellectar Biosciences Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 240 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Cellectar Biosciences Inc . While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 570 to 625.

What is Quick Ratio?
Learn more about CLRB
Quick Ratio CLRB in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 241
Sector # 391
S&P 500 # 624


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
12.96 7.5 4.17
(Sep 30 2021)   (Mar 31 2020)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Acurx Pharmaceuticals inc   14.67 
Cerevel Therapeutics Holdings Inc   14.50 
Adicet Bio Inc   14.48 
Graybug Vision Inc   14.46 
Tyme Technologies Inc.  14.37 
Bio path Holdings Inc  14.37 
Prothena Corporation Public Limited Company  14.24 
Rocket Pharmaceuticals Inc   14.22 
Magenta Therapeutics Inc   14.10 
Lianbio  13.97 
Syndax Pharmaceuticals Inc   13.82 
Ventyx Biosciences Inc   13.73 
Xenetic Biosciences Inc   13.69 
Renovorx Inc   13.67 
Cryoport inc   13.39 
Stealth Biotherapeutics Corp  13.30 
Annexon Inc   13.19 
Galecto Inc   13.16 
Dyne Therapeutics Inc   13.11 
Shattuck Labs Inc   13.09 
Moleculin Biotech Inc   13.05 
Arcutis Biotherapeutics Inc   12.94 
Moonlake Immunotherapeutics  12.74 
Diffusion Pharmaceuticals Inc   12.70 
Avidity Biosciences Inc   12.63 
Iveric Bio Inc   12.60 
Cormedix Inc   12.50 
Uniqure N v   12.47 
Immutep Limited  12.47 
Oncternal Therapeutics Inc   12.25 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BUKS's Profile

Stock Price

BUKS's Financials

Business Description

Fundamentals

Charts & Quotes

BUKS's News

Suppliers

BUKS's Competitors

Customers & Markets

Economic Indicators

BUKS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071